No Data
No Data
Roche Stock to Benefit From Accu-Chek Smartguide Launch in Europe
Is DexCom Stock Underperforming the S&P 500?
Three 'Buys,' Three 'Sells,' and a 'Hold,' by Oppenheimer Analysts
3 Reasons DexCom Looks Like a No-Brainer Buy Right Now
Dexcom CGM Worn in Outer Space as Part of First-of-its-Kind Polaris Dawn Mission
Analysts' Top Healthcare Picks: Dexcom (DXCM), Ascendis Pharma (ASND)